Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

Aspirin has recently been questioned as a preventive for heart attacks, even though we have been using it for decades. Statin ...

In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

More information: P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials, The BMJ (2025). DOI: 10.1136/bmj-2024-082561 ...

The idea that aspirin is such a “wonder drug” is the subject of intense research, but the picture is muddled. The notion that aspirin could have anti-cancer properties dates back decades.

According to the report, the "aspirin drugs market" was valued at $1.3 billion in 2023, and is estimated to reach $1.8 billion by 2035, growing at a CAGR of 2.7% from 2024 to 2035.

A surprisingly large amount of non-aspirin nonsteroidal anti-inflammatory drug (NAN-SAID) usage occurs in the United States, with estimates of as many as 30 billion tablets consumed per year.

A recent study has revealed that an aspirin a day may stop cancer from spreading. In 2025, over 2 million new cancer cases are expected in the U.S., with more than 618,000 deaths—about 1,700 per ...

Additionally, a 2016 study found that long-term aspirin use was linked to a lower risk for overall cancer—specifically gastrointestinal tract tumors—while a 2020 study found that aspirin ...